AG
FBIO icon

AmeriFlex Group’s Fortress Biotech FBIO Stock Holding History

AmeriFlex Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,400
Closed -$6.86K – 1124
2025
Q1 		$6.86K Hold
4,400
– – ﹤0.01% 940
2024
Q4 		$8.01K Buy
+4,400
New +$7.97K ﹤0.01% 828

Other funds holding FBIO

SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

AmeriFlex Group's FBIO Position: Q2 2025 in Review

AmeriFlex Group sold out of Fortress Biotech (FBIO) in Q2 2025, closing a stake of 4,400 shares — an estimated $6.86K sold.

AmeriFlex Group first reported a position in FBIO in Q4 2024 and held it in 2 quarters. The position peaked at $8.01K in Q4 2024. 49 funds tracked by Wall St. Rank hold FBIO as of Q2 2025.

  • AmeriFlex Group reported no remaining Fortress Biotech position as of Q2 2025 after selling out during the quarter.
  • AmeriFlex Group sold 4,400 Fortress Biotech shares in Q2 2025, an estimated $6.86K.
  • AmeriFlex Group first reported a position in Fortress Biotech in Q4 2024 and held it in 2 quarters.
  • AmeriFlex Group's Fortress Biotech position peaked at $8.01K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2025.

Based on AmeriFlex Group's 13F filing for Q2 2025, filed 21 Jul 2025.